Get started
Work

Supplemental Figure 1 from A Phase I/Ib Study of Enzalutamide Alone and in Combination with Endocrine Therapies in Women with Advanced Breast Cancer

Year: 2023
Type: supplementary-materials
Abstract: Individual and mean plasma exposures (AUCtau or Cmin) to endocrine therapies alone or in combination with enzalutamide. Note: Box plots provide the mean (red line), median (black line), and 25%/75% quartiles with whiskers to the last point within 1.5-times interquartile range. Sample sizes are reported in Table 2 in the article.
DOI: 10.1158/1078-0432.22469247.v1
Authors: Lee S. Schwartzberg, Denise A. Yardley, Anthony D. Elias, Manish Patel, Patricia LoRusso, Howard A. Burris, Ayca Gucalp, Amy C. Peterson, Martha E. Blaney, Joyce L. Steinberg, Jacqueline A. Gibbons, Tiffany A. Traina
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361967698
Cites:
Cited by:
Related to: 10